SEC Comment Letter for Itamar Medical Ltd. (CIK 0001613170) — Nov 23, 2020
Itamar Medical Ltd. (CIK 0001613170)
Date: Nov. 23, 2020 · CIK: 0001613170 · Accession: 0000000000-20-011213
AI Filing Summary & Sentiment
File numbers found in text: 333-250155
Letter
United States securities and exchange commission logo November 23, 2020 Gilad Glick Chief Executive Officer Itamar Medical Ltd. 9 Halamish Street Caesarea 3088900, Israel Re:Itamar Medical Ltd. Registration Statement on Form F-3 Filed November 18, 2020 File No. 333-250155 Dear Mr. Glick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nathan Ajiashvili, Esq.
Show Raw Text
United States securities and exchange commission logo
November 23, 2020
Gilad Glick
Chief Executive Officer
Itamar Medical Ltd.
9 Halamish Street
Caesarea 3088900, Israel
Re:Itamar Medical Ltd.
Registration Statement on Form F-3
Filed November 18, 2020
File No. 333-250155
Dear Mr. Glick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nathan Ajiashvili, Esq.